Jan Mueller-Berghaus

Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4<b>+</b> T Cell Responses Against MAGE-6 in HLA-DRB10401<b>+</b> Patients With Renal Cell Carcinoma or Melanoma

Tomohide Tatsumi, Lisa Kierstead, Elena Ranieri et al. · The Journal of Experimental Medicine · 2002 · 305 citations · Full text

Disease-associated Bias, T-regulatory Cell, Immunology +23

B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact Prognosis

Selma Ugurel, Ranjit K. Thirumaran, Sandra Bloethner et al. · PLoS ONE · 2007 · 133 citations · Full text

Genetics, Pathology, Favorable Prognosis +19

PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells

Ravikumar Muthuswamy, Jan Mueller-Berghaus, Uwe Haberkorn et al. · Blood · 2010 · 116 citations · Full text

The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Iordanis Gravanis, Kyriaki Tzogani, Paula B. van Hennik et al. · The Oncologist · 2015 · 46 citations · Full text

In vitro cytokine release assays for predicting cytokine release syndrome: The current state-of-the-science. Report of a European Medicines Agency Workshop

Jean-Marc Vidal, Thomas T. Kawabata, Robin Thorpe et al. · Cytokine · 2010 · 42 citations

Inflammation, Cytokine, Translational Medicine +9